Delivery Order SPE2DB22D2005-SPE2DB24FJKA2
- Not listed
- The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML. The $15,883.20 contract has a completion date of March 8, 2024 and was awarded on March 7, 2024. Amerisourcebergen Drug Corp, as a prime contractor, has been awarded numerous pharmaceutical and medical supply contracts by DLA to support military...
- The Department of Defense's Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a potential value of $31,766.40 and a completion date of January 30, 2024. Amerisourcebergen Drug Corp, a for-profit organization, will deliver the pharmaceutical items to support military...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution firm Amerisourcebergen Corporation. The $15,726.44 contract is for the delivery of 0.5 ML VAXNEUVANCE syringes to support DLA Troop Support Medical programs and facilities. Amerisourcebergen Drug Corp, through its Corporate Office division, has an established history of supplying pharmaceuticals, medical supplies, and...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $13,218.89 firm-fixed-price delivery order contract to Amerisourcebergen Drug Corp's Corporate Office Division to supply the VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical product. This award is part of Amerisourcebergen's $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and...
- The U.S. Defense Logistics Agency (DLA) awarded a firm fixed price delivery order worth $19,736.81 to AmerisourceBergen Drug Corp, a subsidiary of parent company Cencora, Inc., for the supply of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. This order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00, which serves as the primary contract vehicle for AmerisourceBergen Drug Corp to deliver pharmaceuticals and medical supplies to DLA...
- Amerisourcebergen Drug Corp, a subsidiary of the Amerisourcebergen Corporation, has been awarded a $8,077.60 firm fixed price delivery order contract by the Defense Logistics Agency (DLA) Troop Support Medical for the provision of 0.5 ml VAXNEUVANCE syringes. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded by DLA to Amerisourcebergen Drug Corp, which serves as the primary vehicle for the company to deliver...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML pharmaceutical products. The contract has a firm fixed price, with a potential value of $22,283.33, and a completion date of March 4, 2024. There is no set-aside designation for this award, which is a delivery order under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC)...
- The Defense Logistics Agency (DLA) awarded a $10,638.89 delivery order to AmerisourceBergen Drug Corp for VAXNEUVANCE 0.5 ML syringes on July 29, 2025, with completion targeted for July 30, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is performing the work at its corporate office location. The delivery order represents pharmaceutical procurement to support federal medical supply...
- This federal contract award, valued at $10,942.26, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of Vaxneuvance 0.5 ML syringes. The contract is a firm fixed price delivery order with a performance period through March 19, 2024. Amerisourcebergen Drug Corp is the prime contractor on this award, and no set-aside designation was used. Amerisourcebergen Drug Corp is also the prime contractor on a...
- This federal contract award is a firm fixed price delivery order valued at $47,580.86, issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The contract is for the delivery of VAXNEUVANCE 0.5 ML SYRINGE 0.5ML, a pharmaceutical product, with a completion date of April 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA,...
- SPE2DB22D2005Indefinite Delivery Contract
- SPE2DB22D2005-SPE2DB24FJKA2Delivery Order
The U.S. Defense Logistics Agency (DLA) awarded Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a $30,618.90 firm fixed price delivery order contract for 0.5 mL VAXNEUVANCE syringes. This delivery order falls under Amerisourcebergen Drug Corp's $999,999,999.00 indefinite delivery contract with DLA to provide pharmaceutical products and medical supplies to military treatment programs and facilities worldwide. The contract does not have a set-aside designation. Amerisourcebergen Drug Corp, a for-profit organization, is the prime contractor on this award, with no major subcontractors indicated. As a leading global pharmaceutical distribution services company, Amerisourcebergen Drug Corp frequently receives DLA contracts to support the Department of Defense's medical material requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.6k | 3/15/24 |